SB202190

SB202190

Contact us: [email protected]

SB202190
MBS808173-5x5mg 5x5mg
EUR 745

SB202190
SIH-473-25MG 25 mg
EUR 292

SB202190
SIH-473-5MG 5 mg
EUR 76.8

SB202190 (FHPI)
A1632-100 100 mg
EUR 80
Description: MAPK Signaling|p38

SB202190 (FHPI)
A1632-5.1 10 mM (in 1mL DMSO)
EUR 44
Description: MAPK Signaling|p38

SB202190 (FHPI)
MBS575414-100mg 100mg
EUR 175

SB202190 (FHPI)
MBS575414-10mg 10mg
EUR 135

SB202190 (FHPI)
MBS575414-200mg 200mg
EUR 225

SB202190 (FHPI)
MBS575414-25mg 25mg
EUR 140

SB202190 (FHPI)
MBS575414-50mg 50mg
EUR 145

SB202190 (FHPI, 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole)
MBS6023840-1mg 1(mg
EUR 345

SB202190 (FHPI, 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole)
MBS6023840-25mg 25mg
EUR 400

SB202190 (FHPI, 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole)
MBS6023840-5mg 5(mg
EUR 475

SB202190 (FHPI, 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole)
MBS6023840-5x5mg 5x5mg
EUR 1990

SB-7720770 2HCl
562446 5.0mg
EUR 400

SB4315242, Free Base [CAS# 301836-41-9]
S-7800 5 mg
EUR 48

SB705498
A8519-10 10 mg
EUR 120
Description: Membrane Transporter/Ion Channel|TRPV1

SB705498
A8519-5 5 mg
EUR 64
Description: Membrane Transporter/Ion Channel|TRPV1

SB705498
A8519-5.1 10 mM (in 1mL DMSO)
EUR 70.4
Description: Membrane Transporter/Ion Channel|TRPV1

SB705498
A8519-50 50 mg
EUR 520
Description: Membrane Transporter/Ion Channel|TRPV1

SB-204990
551029 1.0mg
EUR 225

SB203850
555153 10.0mg
EUR 265

SB-297006
555605 100.0mg
EUR 450

SB269652
522353 5.0mg
EUR 255

SB-366791
522592 50.0mg
EUR 250

SB-265610
526278 10.0mg
EUR 250

SB-222200
526724 50.0mg
EUR 450

SB-408124
526763 5.0mg
EUR 150

SB649868
526934 100.0mg
EUR 1550

SB-756050
528518 100.0mg
EUR 350

SB328437
532664 10.0mg
EUR 325

SB452533
532670 10.0mg
EUR 345

SB-216763
401903 10.0mg
EUR 150

SB-431542
401910 10.0mg
EUR 90

SB-590885
406109 50.0mg
EUR 450

SB505124
406135 5.0mg
EUR 90

SB239063
406337 5.0mg
EUR 310

SB-218078
406348 1.0mg
EUR 295

SB525334
406415 10.0mg
EUR 150

SB225002
406514 50.0mg
EUR 450

SB-242235
510235 10.0mg
EUR 285

SB-202190
510242 50.0mg
EUR 300

SB-715992
2468-25 each
EUR 836.4

SB-715992
2468-5 each
EUR 261.6

SB-525334
2880-25 each
EUR 757.2

SB-525334
2880-5 each
EUR 235.2

SB-742457
9568-25 each
EUR 652.8

SB-742457
9568-5 each
EUR 210

SB-431542
1674-1 each
EUR 202.8

SB-431542
1674-5 each
EUR 535.2

SB-366791
20-abx076632
  • Ask for price
  • Ask for price
  • 10 mg
  • 50 mg

SB-366791
abx076632-250l 250 µl
EUR 131.25

SB-366791
abx076632-500l 500 µl
EUR 337.5

SB-202190
abx076748-100l 100 µl
EUR 93.75

SB-202190
abx076748-1ml 1 ml Ask for price

SB-202190
abx076748-200l 200 µl
EUR 187.5

SB-216763
abx076766-100l 100 µl
EUR 118.75

SB-216763
abx076766-1ml 1 ml Ask for price

SB-216763
abx076766-200l 200 µl
EUR 275

SB216763
20-abx076766
  • Ask for price
  • Ask for price
  • 5 mg
  • 25 mg

SB-431542
abx076786-100l 100 µl
EUR 143.75

SB-431542
abx076786-1ml 1 ml Ask for price

SB-431542
abx076786-200l 200 µl
EUR 312.5

SB431542
20-abx076786
  • Ask for price
  • Ask for price
  • 5 mg
  • 25 mg

SB-203580
abx076800-100l 100 µl
EUR 131.25

SB-203580
abx076800-1ml 1 ml Ask for price

SB-203580
abx076800-200l 200 µl
EUR 337.5

SB203580
20-abx076800
  • Ask for price
  • Ask for price
  • 5 mg
  • 25 mg

SB525334
A5602-100 100 mg
EUR 384
Description: Tyrosine Kinase|ALK#TGF-β / Smad Signaling|TGF-βR1(ALK5)

SB525334
A5602-25 25 mg
EUR 120
Description: Tyrosine Kinase|ALK#TGF-β / Smad Signaling|TGF-βR1(ALK5)

SB525334
A5602-5 5 mg
EUR 40
Description: Tyrosine Kinase|ALK#TGF-β / Smad Signaling|TGF-βR1(ALK5)

SB525334
A5602-5.1 10 mM (in 1mL DMSO)
EUR 40
Description: Tyrosine Kinase|ALK#TGF-β / Smad Signaling|TGF-βR1(ALK5)

SB525334
A5602-S Evaluation Sample
EUR 24
Description: Tyrosine Kinase|ALK#TGF-β / Smad Signaling|TGF-βR1(ALK5)

SB-222200
A3795-10 10 mg
EUR 96
Description: GPCR/G protein|NK3 Receptor

SB-222200
A3795-5.1 10 mM (in 1mL DMSO)
EUR 104
Description: GPCR/G protein|NK3 Receptor

SB-222200
A3795-50 50 mg
EUR 412.8
Description: GPCR/G protein|NK3 Receptor

SB-674042
A3800-10 10 mg
EUR 203.2
Description: GPCR/G protein|OX Receptor

SB-674042
A3800-25 25 mg
EUR 717.6
Description: SB-674042 is a specific, high-affinity OX1 selective antagonist.

SB-674042
A3800-5 5 mg
EUR 121.6
Description: GPCR/G protein|OX Receptor

SB743921
B1590-10 10 mg
EUR 167.2
Description: Cell Cycle/Checkpoint|Ksp

SB743921
B1590-200 200 mg
EUR 1314.4
Description: Cell Cycle/Checkpoint|Ksp

SB743921
B1590-50 50 mg
EUR 516
Description: Cell Cycle/Checkpoint|Ksp

SB239063
B1699-25 each
EUR 652.8

SB239063
B1699-5 each
EUR 210

SB-590885
B1708-25 each
EUR 652.8

SB-590885
B1708-5 each
EUR 210

SB-415286
B1954-25 each
EUR 907.2

SB-415286
B1954-5 each
EUR 274.8

SB408124
B2163-10 10 mg
EUR 68
Description: GPCR/G protein|OX Receptor

SB408124
B2163-100 100mg
EUR 432
Description: GPCR/G protein|OX Receptor

SB408124
B2163-25 25 mg
EUR 152
Description: GPCR/G protein|OX Receptor

SB408124
B2163-5 5 mg
EUR 40
Description: GPCR/G protein|OX Receptor

SB408124
B2163-50 50 mg
EUR 710.4
Description: SB408124 is a potent and novel nonpeptide antagonist of orexin-1 (OX(1)) receptor with Ki values of 27 nM and 57 nM in membrane formats and in whole cell, respectively. SB408124 was 50-fold selective over the human OX2 receptor [1].

SB-334867
B1281-25 25 mg
EUR 324
Description: SB-334867 is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867
B1281-5.1 10 mM (in 1mL DMSO)
EUR 142.8
Description: SB-334867 is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB271046
B2255-10 10 mg
EUR 201.6
Description: SB-271046 is a selective and orally active 5-HT6 receptor antagonist.5-HT6 belongs to GPCR which stimulates adenylate cyclase via Gs, which cloned from rat striatum.

SB271046
B2255-50 50 mg
EUR 614.4
Description: SB-271046 is a selective and orally active 5-HT6 receptor antagonist.5-HT6 belongs to GPCR which stimulates adenylate cyclase via Gs, which cloned from rat striatum.

SB271046
B2255-S Evaluation Sample
EUR 97.2
Description: SB-271046 is a selective and orally active 5-HT6 receptor antagonist.5-HT6 belongs to GPCR which stimulates adenylate cyclase via Gs, which cloned from rat striatum.

SB742457
B2256-25 25 mg
EUR 264
Description: GPCR/G protein|5-HT Receptor#Neuroscience|5-HT Receptor

SB742457
B2256-5 5 mg
EUR 84
Description: GPCR/G protein|5-HT Receptor#Neuroscience|5-HT Receptor

SB742457
B2256-5.1 10 mM (in 1mL DMSO)
EUR 125.6
Description: GPCR/G protein|5-HT Receptor#Neuroscience|5-HT Receptor

SB-242235
B2273-25 each
EUR 614.4

SB-242235
B2273-5 each
EUR 210

SB505124
B2289-10 10 mg
EUR 94.4
Description: ALK4/ALK5/ALK7 inhibitor

SB505124
B2289-50 50 mg
EUR 296.8
Description: ALK4/ALK5/ALK7 inhibitor

SB590885
B1406-10 10 mg
EUR 96
Description: MAPK Signaling|Raf

SB590885
B1406-100 100 mg
EUR 624
Description: MAPK Signaling|Raf

SB590885
B1406-250 250 mg
EUR 1104
Description: MAPK Signaling|Raf

SB590885
B1406-5.1 10 mM (in 1mL DMSO)
EUR 120
Description: MAPK Signaling|Raf

SB590885
B1406-50 50 mg
EUR 384
Description: MAPK Signaling|Raf

SB-204490
B2507-1 each
EUR 157.2

SB-204490
B2507-5 each
EUR 418.8

SB-297006
B2589-25 each
EUR 548.4

SB-297006
B2589-5 each
EUR 183.6

SB-225002
abx282811-100g 100 µg Ask for price

SB-225002
abx282811-20g 20 µg
EUR 131.25

SB-225002
abx282811-50g 50 µg
EUR 337.5

SB-525334
abx282848-100g 100 µg Ask for price

SB-525334
abx282848-20g 20 µg
EUR 131.25

SB-525334
abx282848-50g 50 µg
EUR 312.5

SB-705498
abx283246-100g 100 µg Ask for price

SB-705498
abx283246-20g 20 µg
EUR 143.75

SB-705498
abx283246-50g 50 µg
EUR 337.5

SB273005
B6003-25 25 mg
EUR 718.4
Description: Angiogenesis|Integrin

SB273005
B6003-5 5 mg
EUR 136
Description: Angiogenesis|Integrin

SB-423562
HY-15105 10mg
EUR 1049.8
Description: SB-423562 is a short-acting calcium-sensing receptor (CaR) antagonist. SB-423562 has the potential for osteoporosis research.

SB-423557
HY-15106 Get quote Ask for price
Description: SB-423557 is an orally active calcium-sensing receptor (CaR) antagonist (IC50=520 nM), precursor of SB-423562 (IC50=73 nM). SB-423557 is well tolerated in human and increases plasma concentrations of exogenous parathyroid hormone (PTH) and stimulates bone formation[1].

SB-649701
HY-153669 Get quote Ask for price
Description: SB-649701 is a potent human CCR8 antagonist, with a pIC50 of 7.7. AZ084 can be used for the research of asthma[1].

SB-269970
HY-15370 50mg
EUR 854.4
Description: SB-269970 is a potent, selective and brain-penetrant 5-HT7 receptor antagonist with a pKi of 8.3. SB-269970 exhibits >50-fold selectivity against other 5-HT receptors[1][2].

SB-525334
GL1664 5mg
EUR 97.14

SB-366791
GL6242 5mg
EUR 273.72

SB-366791
GL6242-25 25
EUR 298.9

SB-366791
GL6242-25MG 25 mg
EUR 385.2

SB-366791
GL6242-5 5
EUR 104.3

SB-366791
GL6242-5MG 5 mg
EUR 157.2

SB216763
G607 1.0 mg
EUR 225
Description: 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione

SB-681323
MBS133317-INQUIRE INQUIRE Ask for price

SB366791
MBS133457-INQUIRE INQUIRE Ask for price

SB297006
MBS132856-INQUIRE INQUIRE Ask for price

SB-271046
MBS130968-100mg 100mg
EUR 1065

SB-271046
MBS130968-500mg 500mg
EUR 2775

SB-705498
MBS131977-100mg 100mg
EUR 1065

SB-705498
MBS131977-500mg 500mg
EUR 2775

SB649868
MBS131824-INQUIRE INQUIRE Ask for price

SB742457
MBS131904-INQUIRE INQUIRE Ask for price

SB224289
MBS131589-100mg 100mg
EUR 1495

SB-505124
MBS132654-100mg 100mg
EUR 1065

SB-505124
MBS132654-500mg 500mg
EUR 2775

SB-202190
MBS131011-100mg 100mg
EUR 1065

SB-202190
MBS131011-500mg 500mg
EUR 2775

SB-202190
MBS131012-100mg 100mg
EUR 1065

SB-202190
MBS131012-500mg 500mg
EUR 2775

SB-265610
HY-50688 10mM/1mL
EUR 854.99
Description: SB-265610 is a selective, competitive, nonpeptide and allosteric CXCR2 antagonist. SB-265610 blocks rat cytokine-induced neutrophil chemoattractant-1 (CINC-1)-induced calcium mobilization and neutrophil chemotaxis with IC50s of 3.7 nM and 70 nM, respectively[1][2].

SB-408124
HY-70068 10mM/1mL
EUR 73.59
Description: SB-408124 is a non-peptide OX1 receptor antagonist with Kis of 57 nM and 27 nM in whole cell and membrane, respectively. SB-408124 exhibits 50-fold selectivity over OX2 receptor[1].

SB-505124
HY-13521 50mg
EUR 514.08
Description: SB-505124 is a selective inhibitor of TGF-β Receptor type I receptors (ALK4, ALK5, ALK7), with IC50s of 129 nM and 47 nM for ALK4, ALK5, respectively, but it does not inhibit ALK1, 2, 3, or 6.

SB-568849
HY-100308 10mg
EUR 3370.8
Description: SB-568849 is a melanin-concentrating hormone receptor 1 (MCH R1) antagonist with a pKi of 7.7.

SB-224289
HY-101105 Get quote Ask for price
Description: SB-224289 is a selective 5-HT1B receptor antagonist, with anxiolytic effect[1].

SB203580
inh-sb20-5 5 x 5 mg
EUR 136.5

SB756050
HY-102016 50mg
EUR 194.81
Description: SB756050 is a selective TGR5 agonist. SB756050 has the potential for type 2 diabetes treatment.

SB-699551
HY-103100 Get quote Ask for price
Description: SB-699551 is a potent and selective 5-HT5A antagonist with a pKi of 8.3[1]. SB-699551 inhibits tumorsphere formation. SB-699551 reduces phosphorylation of AKT at serine residue 473 (S473), WNK1, PRAS40. SB-699551 shows anticancer activity and has the potential for the research of breast tumor[2][3].

SB-200646
HY-103129A Get quote Ask for price
Description: SB-200646 is the first selective 5-HT2B/2C over 5-HT2A receptor antagonist with pKi values of 7.5, 6.9 and 5.2 for 5-HT2B, 5-HT2C and 5-HT2A, respectively. SB-200646 is orally active and has electrophysiological and anxiolytic properties in vivo[1][2].

SB228357
HY-103154 5mg
EUR 703.47
Description: SB228357 is a selective, potent and orall active 5-HT2C/2B receptor antagonist with pKi values of 6.9, 8.0 and 9.0 for 5-HT2A, 5-HT2B and 5-HT2C, respectively. SB228357 has antidepressant/anxiolytic effects[1][2].

SB-221284
HY-103155 Get quote Ask for price
Description: SB 221284 is a selective 5-HT2C/2B receptor antagonist with pKi values are 6.4, 7.9 and 8.6 for 5-HT2A, 5-HT2B and 5-HT2C receptors, respectively. SB 221284 can be used for the research of neurological disease[1].

SB297006
HY-103361 5mg
EUR 487.02
Description: SB297006 is a CCR3 antagonist, which significantly inhibits proliferation and neurosphere formation in CCL11-treated neural progenitor cells.

SB-328437
HY-103363 10 mg
EUR 671.01
Description: SB-328437 is a potent, selective non-peptide CCR3 antagonist with an IC50 of 4.5 nM[1].

SB-205384
HY-103501 5mg
EUR 660.18
Description: SB-205384 is a GABAA receptor modulator. The primary effect of SB-205384 on GABAA-activated currents is a prolonged response decay half-life upon removal of the agonist[1].

SB-431542
HY-10431 100mg
EUR 389.62
Description: SB-431542 is a TGF-β receptor kinase inhibitor (TRKI). SB-431542 has inhibitory activity for ALK4, ALK5 and ALK7 with IC50 values of 1 μM, 0.75 μM and 2 μM, respectively. SB-431542 also inhibits TGF-β-induced transcription, gene expression, apoptosis, and growth suppression. SB-431542 can be used for the research of cancer and signal transduction pathways[1][2][3].

SB399885
HY-105896 Get quote Ask for price
Description: SB399885 is a potent, selective, brain penetrant and orally active 5-HT6 receptor antagonist with pKi values 9.11 and 9.02 for human recombinant and native 5-HT6 receptors, respectively. SB399885 has cognitive enhancing properties[1].

SB-705498
HY-10633 100mg
EUR 773.82
Description: SB-705498 is a potent, selective and orally bioavailable transient receptor potential vanilloid 1 (TRPV1) receptor antagonist with a pIC50 of 7.1.

SB-657510
HY-10656 10mg
EUR 1298.72
Description: SB-657510 is a selective urotensin II (UII) receptor (UT) antagonist. The Ki values are 61, 17, 30, 65 and 56 nM for human, monkey, cat, rat and mouse receptors, respectively. SB-657510 exerts anti-inflammatory effects by inhibiting UII-induced upregulation of inflammatory mediators such as adhesion molecules, cytokines, and tissue factor in human vascular endothelial cells[1][2].

SB-611812
HY-10664 1 mg
EUR 1136.38
Description: SB-611812 is a urotensin II receptor (UTR) antagonist with the potential in the research of cardiovascular disease[1][2].

SB-218078
HY-107407 1 mg
EUR 149.35
Description: SB-218078 is a potent, selective, ATP-competitive and cell-permeable checkpoint kinase 1 (Chk1) inhibitor that inhibits Chk1 phosphorylation of cdc25C with an IC50 of 15 nM. SB-218078 is less potently inhibits Cdc2 (IC50 of 250 nM) and PKC (IC50 of 1000 nM). SB-218078 causes apoptosis by DNA damage and cell cycle arrest[1][2][3].

SB-649868
HY-10806 100mg
EUR 2532.51
Description: SB-649868 is a potent and selective orally active orexin (OX) 1 and OX2 receptor antagonist (pKi =9.4 and 9.5 at the OX1 and OX2 receptor, respectively).

SB-633825
HY-108333 10 mg
EUR 2056.31
Description: SB-633825 is a potent and ATP-competitive inhibitor of TIE2, LOK (STK10) and BRK with IC50s of 3.5 nM, 66 nM, 150 nM, respectively. SB-633825 can inhibit cancer cell growth and angiogenesis[1].

SB-277011
HY-10847 50mg
EUR 1315.2

SB-334867
HY-10895 50mg
EUR 557.37
Description: SB-334867 (SB 334867A) is an excellent,selective and blood–brain barrier permeable orexin-1 (OX1) receptor antagonist, shows selectivity over OX2 (pKb=7.4), 100-fold over 5-HT2B, 5-HT2C with pKi values of 5.4 and 5.3, respectively[1]. SB-334867 reduces ethanol consumption and inhibits the acquisition of morphine-induced sensitization to locomotor activity in vivo[2][3].

SB-674042
HY-10898 10mM/1mL
EUR 141.78
Description: SB-674042 is a potent and selective non-peptide orexin OX1 receptor antagonist (Kd=5.03 nM), exhibits 100-fold selectivity for OX1 over OX2 receptors with IC50 values of 3.76 nM and 531 nM, respectively[1][4].

SB-590885
HY-10966 10mM/1mL
EUR 671.01
Description: SB-590885 is a potent B-Raf inhibitor with Ki of 0.16 nM, and has 11-fold greater selectivity for B-Raf over c-Raf, without inhibition to other human kinases.

SB-734117
HY-114005 1mg
EUR 342
Description: SB-734117 is a human cytomegalovirus (HCMV) replication inhibitor that prevents CREB and histone H3 post-translational modifications[1].

SB-222200
HY-15722 10mg
EUR 799.8
Description: SB-222200 is a potent, selective, orally active and blood-brain barrier (BBB) penetrant NK-3 receptor antagonist. SB-222200 is developed for central nervous system (CNS) disorders[1].

SB225002
HY-16711 100mg
EUR 345.24
Description: SB225002, a potent, selective and non-peptide CXCR2 antagonist, inhibits 125I-IL-8 binding to CXCR2 with an IC50 of 22 nM.

SB-332235
HY-16981 10 mg
EUR 651.53
Description: SB-332235 is a potent, orally active nonpeptide CXCR2 antagonist, with an IC50 of 7.7 nM. SB-332235 displays 285-fold selectivity for CXCR2 over CXCR1. SB-332235 inhibits acute and chronic models of arthritis in the rabbit. SB-332235 inhibits viability of AML cells[1][2].

SB-215505
HY-18596 Get quote Ask for price
Description: SB-215505 is a potent and subtype-selective 5-HT2B receptor antagonist with pKi values of 8.3, 6.77, 7.66 for 5-HT2B, 5-HT2A, 5-HT2C, respectively[1]. SB-215505 increases wakefulness and motor activity in rats[2].

SB-612111
HY-18618 Get quote Ask for price
Description: SB-612111 is a novel and potent opiate receptor-like orphan receptor (ORL-1) antagonist with a high affinity for hORL-1 (Ki=0.33 nM). SB-612111 exhibits selectivity for μ-, κ- and δ-receptors with Ki values of 57.6 nM, 160.5 nM and 2109 nM, respecticely. SB-612111 effectively antagonizes the pronociceptive action of Nociceptin (HY-P0183) in an acute pain model[1].

SB-209670
HY-19210 1mg
EUR 617.98
Description: SB-209670 is an extremely potent and highly specific non-peptide, subnanomolar endothelin (ET) receptor antagonist. SB 209670 selectively inhibits binding of 125I-labeled ET-1 to cloned human ET receptor subtypes ETA and ETB (Ki=0.2 and 18 nM, respectively). SB 209670 produces a dose-dependent reduction in blood pressure in hypertensive rats, protects from ischemia-induced neuronal degeneration in a gerbil stroke model, and attenuates neointima formation following rat carotid artery balloon angioplasty[1].

SB-267268
HY-19306 1 mg
EUR 2759.78
Description: SB-267268 is a selective and nonpeptidic alpha(v)beta3 (αvβ3) and alpha(v)beta5 (αvβ5) integrins antagonist, with Kis of 0.9, 0.5 and 0.7 nM for human αvβ3, monkey αvβ3 and human αvβ5, respectively. SB-267268 inhibits human and mouse αvβ3 with IC50s of 0.68 and 0.29 nM, respectively. SB-267268 reduces angiogenesis and VEGF expression[1].

SB-273005
HY-19307 1 mg
EUR 811.7
Description: SB-273005 is a potent nonpeptide and orally active integrin antagonist with Kis of 1.2 nM and 0.3 nM for αvβ3 receptor and αvβ5 receptor, respectively[1].

SB-435495
HY-19415 10 mg
EUR 974.04
Description: SB-435495 is a potent, selective, reversible, non-covalent and orally active Lp-PLA2 inhibitor with an IC50 of 0.06 nM[1][3].

SB-408124
E1KS1545 5mg
EUR 211.2

SB202190